secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcturus Therapeutics Holdings Inc. (ARCT)
CIK:        0001768224
Form:       8-K
Filed at:   2026-08-25T10:00:33+00:00
Accession:  0001193805-26-001130
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcturus to present ARCT-810 OTC deficiency data at SSIEM 2026
--------------------------------------------------------------

- Poster on ARCT-810 mRNA therapy for ornithine transcarbamylase deficiency at SSIEM 2026 in Helsinki on Aug 25, 2026
- Data covers dietary intake and biochemical outcomes in adolescents and adults
- Additional data and regulatory plan expected later this quarter
- Presentation furnished as Exhibit 99.1 to Form 8-K

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1768224/000119380526001130/0001193805-26-001130-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1768224/000119380526001130/e665725_8k-arct.htm
  HTML page:      https://secwatch.observer/filing/0001193805-26-001130

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer